Lipidoid Tail Structure Strongly Influences siRNA Delivery Activity

Cellular and Molecular Bioengineering

Volumn 9, Issue 3, 2016, Pages 305-314

  Knapp, Christopher M ^a   Guo, Penghong ^a   Whitehead, Kathryn A ^a  

^a CARNEGIE MELLON UNIVERSITY   (United States)

Author keywords

Hepatocellular delivery; Lipid nanoparticles; Nanomedicine; RNA interference; siRNA delivery; Structure function

Indexed keywords

ACRYLIC ACID; ALIPHATIC AMINE; BLOOD CLOTTING FACTOR 7; ETHER; ISODECYL ACRYLATE; LIPIDOID NANOPARTICLE; METHACRYLIC ACID; NANOPARTICLE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ACID DISSOCIATION CONSTANT; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GENE SILENCING; HELA CELL LINE; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNAI THERAPEUTICS;

EID: 84963682649     PISSN: 18655025     EISSN: 18655033     Source Type: Journal    
DOI: 10.1007/s12195-016-0436-9     Document Type: Article

References (30)

1. Akinc, A., W. Querbes, S. De, J. Qin, M. Frank-Kamenetsky, K. N. Jayaprakash, M. Jayaraman, K. G. Rajeev, W. L. Cantley, J. R. Dorkin, J. S. Butler, L. Qin, T. Racie, A. Sprague, E. Fava, A. Zeigerer, M. J. Hope, M. Zerial, D. W. Sah, K. Fitzgerald, M. A. Tracy, M. Manoharan, V. Koteliansky, A. de Fougerolles, and M. A. Maier. Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms. Mol. Ther. 18:1357–1364, 2010.
2. Akinc, A., A. Zumbuehl, M. Goldberg, E. S. Leshchiner, V. Busini, N. Hossain, S. A. Bacallado, D. N. Nguyen, J. Fuller, R. Alvarez, A. Borodovsky, T. Borland, R. Constien, A. De Fougerolles, J. R. Dorkin, K. Narayanannair Jayaprakash, M. Jayaraman, M. John, V. Koteliansky, M. Manoharan, L. Nechev, J. Qin, T. Racie, D. Raitcheva, K. G. Rajeev, D. W. Y. Sah, J. Soutschek, I. Toudjarska, H. Vornlocher, T. S. Zimmermann, R. Langer, and D. G. Anderson. A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nat. Biotechnol. 26:561–569, 2008.
3. Alabi, C. A., K. T. Love, G. Sahay, H. Yin, K. M. Luly, R. Langer, and D. G. Anderson. Multiparametric approach for the evaluation of lipid nanoparticles for siRNA delivery. Proc. Natl. Acad. Sci. 110:12881–12886, 2013.
4. Ameres, S. L., J. Martinez, and R. Schroeder. Molecular basis for target RNA recognition and cleavage by human RISC. Cell 130:101–112, 2007.
5. Chen, C.-K., W.-C. Law, R. Aalinkeel, B. Nair, A. Kopwitthaya, S. D. Mahajan, J. L. Reynolds, J. Zou, S. A. Schwartz, P. N. Prasad, and C. Cheng. Well-defined degradable cationic polylactide as nanocarrier for the delivery of siRNA to silence angiogenesis in prostate cancer. Adv. Healthc. Mater. 1:751–761, 2012.
6. Dong, Y., K. T. Love, J. R. Dorkin, S. Sirirungruang, Y. Zhang, D. Chen, R. L. Bogorad, H. Yin, Y. Chen, A. J. Vegas, C. A. Alabi, G. Sahay, K. T. Olejnik, W. Wang, A. Schroeder, A. K. R. Lytton-Jean, D. J. Siegwart, A. Akinc, C. Barnes, S. A. Barros, M. Carioto, K. Fitzgerald, J. Hettinger, V. Kumar, T. I. Novobrantseva, J. Qin, W. Querbes, V. Koteliansky, R. Langer, and D. G. Anderson. Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates. Proc. Natl. Acad. Sci. 111:3955–3960, 2014.
7. Fire, A., S. Xu, M. K. Montgomery, S. A. Kostas, S. E. Driver, and C. C. Mello. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391:806–811, 1998.
8. Fitzgerald, K., M. Frank-Kamenetsky, S. Shulga-Morskaya, A. Liebow, B. R. Bettencourt, J. E. Sutherland, R. M. Hutabarat, V. A. Clausen, V. Karsten, J. Cehelsky, S. V. Nochur, V. Kotelianski, J. Horton, T. Mant, J. Chiesa, J. Ritter, M. Munisamy, A. K. Vaishnaw, J. A. Gollob, and A. Simon. Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial. Lancet 383:60–68, 2014.
9. Frank-Kamenetsky, M., A. Grefhorst, N. N. Anderson, T. S. Racie, B. Bramlage, A. Akinc, D. Butler, K. Charisse, R. Dorkin, Y. Fan, C. Gamba-Vitalo, P. Hadwiger, M. Jayaraman, M. John, K. N. Jayaprakash, M. Maier, L. Nechev, K. G. Rajeev, T. Read, I. Röhl, J. Soutschek, P. Tan, J. Wong, G. Wang, T. Zimmermann, A. de Fougerolles, H.-P. Vornlocher, R. Langer, D. G. Anderson, M. Manoharan, V. Koteliansky, J. D. Horton, and K. Fitzgerald. Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates. Proc. Natl. Acad. Sci. 105:11915–11920, 2008.
10. Gilleron, J., W. Querbes, A. Zeigerer, A. Borodovsky, G. Marsico, U. Schubert, K. Manygoats, S. Seifert, C. Andree, M. Stöter, H. Epstein-Barash, L. Zhang, V. Koteliansky, K. Fitzgerald, E. Fava, M. Bickle, Y. Kalaidzidis, A. Akinc, M. Maier, and M. Zerial. Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape. Nat. Biotechnol. 31:638–646, 2013.
11. Heyes, J., L. Palmer, K. Bremner, and I. MacLachlan. Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids. J. Control. Release 107:276–287, 2005.
12. Jayaraman, M., S. M. Ansell, B. L. Mui, Y. K. Tam, J. Chen, X. Du, D. Butler, L. Eltepu, S. Matsuda, J. K. Narayanannair, K. G. Rajeev, I. M. Hafez, A. Akinc, M. A. Maier, M. A. Tracy, P. R. Cullis, T. D. Madden, M. Manoharan, and M. J. Hope. Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo. Angew. Chem. Int. Ed. 51:8529–8533, 2012.
13. Kumar, V., J. Qin, Y. Jiang, R. G. Duncan, B. Brigham, S. Fishman, J. K. Nair, A. Akinc, S. A. Barros, and P. V. Kasperkovitz. Shielding of lipid nanoparticles for siRNA delivery: impact on physicochemical properties, cytokine induction, and efficacy. Mol. Ther. Nucl. Acids 3:e210, 2014.
14. Love, K. T., K. P. Mahon, C. G. Levins, K. A. Whitehead, W. Querbes, J. R. Dorkin, J. Qin, W. Cantley, L. L. Qin, T. Racie, M. Frank-Kamenetsky, K. N. Yip, R. Alvarez, D. W. Y. Sah, A. de Fougerolles, K. Fitzgerald, V. Koteliansky, A. Akinc, R. Langer, and D. G. Anderson. Lipid-like materials for low-dose, in vivo gene silencing. Proc. Natl. Acad. Sci. 107:1864–1869, 2010.
15. Mahon, K. P., K. T. Love, K. A. Whitehead, J. Qin, A. Akinc, E. Leshchiner, I. Leshchiner, R. Langer, and D. G. Anderson. Combinatorial approach to determine functional group effects on lipidoid-mediated siRNA delivery. Bioconjugate Chem. 21:1448–1454, 2010.
16. Rand, T. A., S. Petersen, F. Du, and X. Wang. Argonaute2 cleaves the anti-guide strand of siRNA during RISC activation. Cell 123:621–629, 2005.
17. Sahay, G., W. Querbes, C. Alabi, A. Eltoukhy, S. Sarkar, C. Zurenko, E. Karagiannis, K. Love, D. Chen, R. Zoncu, Y. Buganim, A. Schroeder, R. Langer, and D. G. Anderson. Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling. Nat. Biotechnol. 31:653–658, 2013.
18. Sehgal, A., S. Barros, L. Ivanciu, B. Cooley, J. Qin, T. Racie, J. Hettinger, M. Carioto, Y. Jiang, J. Brodsky, H. Prabhala, X. Zhang, H. Attarwala, R. Hutabarat, D. Foster, S. Milstein, K. Charisse, S. Kuchimanchi, M. A. Maier, L. Nechev, P. Kandasamy, A. V. Kel’in, J. K. Nair, K. G. Rajeev, M. Manoharan, R. Meyers, B. Sorensen, A. R. Simon, Y. Dargaud, C. Negrier, R. M. Camire, and A. Akinc. An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia. Nat. Med. 21:492–497, 2015.
19. Semple, S. C., A. Akinc, J. Chen, A. P. Sandhu, B. L. Mui, C. K. Cho, D. W. Y. Sah, D. Stebbing, E. J. Crosley, E. Yaworski, I. M. Hafez, J. R. Dorkin, J. Qin, K. Lam, K. G. Rajeev, K. F. Wong, L. B. Jeffs, L. Nechev, M. L. Eisenhardt, M. Jayaraman, M. Kazem, M. A. Maier, M. Srinivasulu, M. J. Weinstein, Q. Chen, R. Alvarez, S. A. Barros, S. De, S. K. Klimuk, T. Borland, V. Kosovrasti, W. L. Cantley, Y. K. Tam, M. Manoharan, M. A. Ciufolini, M. A. Tracy, A. de Fougerolles, I. MacLachlan, P. R. Cullis, T. D. Madden, and M. J. Hope. Rational design of cationic lipids for siRNA delivery. Nat. Biotechnol. 28:172–176, 2010.
20. Wang, M., S. Sun, K. A. Alberti, and Q. Xu. A combinatorial library of unsaturated lipidoids for efficient intracellular gene delivery. ACS Synth. Biol. 1:403–407, 2012.
21. Whitehead, K.A., J.R. Dorkin, A.J. Vegas, P.H. Chang, O. Veiseh, J. Matthews, O.S. Fenton, Y. Zhang, K.T. Olejnik, V. Yesilyurt, D. Chen, S. Barros, B. Klebanov, T. Novobrantseva, R. Langer, and D.G. Anderson. Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity. Nat. Commun. 5, 2014 [cited 2014 Oct 7]. Available from: http://www.nature.com/ncomms/2014/140627/ncomms5277/full/ncomms5277.html.
22. Whitehead, K. A., R. Langer, and D. G. Anderson. Knocking down barriers: advances in siRNA delivery. Nat. Rev. Drug Discov. 8:129–138, 2009.
23. Whitehead, K. A., J. Matthews, P. H. Chang, F. Niroui, J. R. Dorkin, M. Severgnini, and D. G. Anderson. In vitro–in vivo translation of lipid nanoparticles for hepatocellular siRNA delivery. ACS Nano 6:6922–6929, 2012.
24. Wisse, E., F. Jacobs, B. Topal, P. Frederik, and B. De Geest. The size of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene transfer. Gene Ther. 15:1193–1199, 2008.
25. Wittrup, A., A. Ai, X. Liu, P. Hamar, R. Trifonova, K. Charisse, M. Manoharan, T. Kirchhausen, and J. Lieberman. Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown. Nat. Biotechnol. 33:870–876, 2015.
26. Wooddell, C. I., D. B. Rozema, M. Hossbach, M. John, H. L. Hamilton, Q. Chu, J. O. Hegge, J. J. Klein, D. H. Wakefield, C. E. Oropeza, J. Deckert, I. Roehl, K. Jahn-Hofmann, P. Hadwiger, H.-P. Vornlocher, A. McLachlan, and D. L. Lewis. Hepatocyte-targeted RNAi therapeutics for the treatment of chronic hepatitis B virus infection. Mol. Ther. 21:973–985, 2013.
27. Yameen, B., W. I. Choi, C. Vilos, A. Swami, J. Shi, and O. C. Farokhzad. Insight into nanoparticle cellular uptake and intracellular targeting. J. Control. Release 190:485–499, 2014.
28. Yu, B., S.-H. Hsu, C. Zhou, X. Wang, M. C. Terp, Y. Wu, L. Teng, Y. Mao, F. Wang, W. Xue, S. T. Jacob, K. Ghoshal, R. J. Lee, and L. J. Lee. Lipid nanoparticles for hepatic delivery of small interfering RNA. Biomaterials 33:5924–5934, 2012.
29. Zhou, K., L. H. Nguyen, J. B. Miller, Y. Yan, P. Kos, H. Xiong, L. Li, J. Hao, J. T. Minnig, H. Zhu, and D. J. Siegwart. Modular degradable dendrimers enable small RNAs to extend survival in an aggressive liver cancer model. Proc. Natl. Acad. Sci. 113:520–525, 2016.
30. Zuckerman, J. E., and M. E. Davis. Clinical experiences with systemically administered siRNA-based therapeutics in cancer. Nat. Rev. Drug Discov. 14:843–856, 2015.